EMEA-001552-PIP01-13

Key facts

Active substance
  • telmisartan
  • Amlodipine besilate
Therapeutic area
Cardiovascular diseases
Decision number
P/0055/2014
PIP number
EMEA-001552-PIP01-13
Pharmaceutical form(s)
Tablet
Condition(s) / indication(s)
Treatment of essential hypertension
Route(s) of administration
Oral use
Contact for public enquiries
Zentiva k.s. 
Czech Republic 
E-mail: blanka.zoubkova@zentiva.com 
Tel. +420 267243574
Decision type
W: decision granting a waiver in all age groups for all conditions or indications

Decision

How useful was this page?

Add your rating